Mucosal Impedance in Pediatric Population
Recruiting in Palo Alto (17 mi)
MV
MA
SA
Overseen bySari Acra, MD
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Vanderbilt University Medical Center
No Placebo Group
Trial Summary
What is the purpose of this trial?
Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.
Research Team
MV
Michael Vaezi, MD, PhD
Principal Investigator
Vanderbilt University Medical Center
MA
Mary Allyson Lowry, MD
Principal Investigator
Vanderbilt University Medical Center
SA
Sari Acra, MD
Principal Investigator
Vanderbilt University Medical Center
Eligibility Criteria
Inclusion Criteria
Patients between 1 year and 18 years of age
Patients who are undergoing standard of care upper endoscopy and biopsy for complaints of dyspepsia
Treatment Details
Interventions
- Standard of Care Esophagogastroduodenoscopy (EGD) with Measurement of Mucosal Impedance (Diagnostic Test)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: EGD with BiopsyExperimental Treatment1 Intervention
Pediatric patients scheduled for standard of care EGD with biopsy also received measurement of mucosal impedance
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Vanderbilt Children's HospitalNashville, TN
Loading ...
Who Is Running the Clinical Trial?
Vanderbilt University Medical Center
Lead Sponsor
Trials
922
Patients Recruited
939,000+
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Trials
2513
Patients Recruited
4,366,000+